Studies have shown that when older adults with cancer get a geriatric assessment, they have: Fewer severe side effects: ...

Keytruda's first approval by US FDA came in the year 2014 for advanced skin cancer. Now, the immunotherapy drug is being used ...

Last year, the Princess of Wales shared that she was in remission following her cancer treatment. Here’s how her health has progressed since then. Kate Middleton’s health has been under close watch ...

Collaboration between oncologists and pharmacists is crucial for optimizing value-based oncology care and overcoming access barriers to therapies and tests. Enhancing access to biomarker testing and ...

6 Myths About Cancer Risk Oncologists Wish You'd Stop Believing ...

GG1 prostate cancer can have heterogeneous outcomes, with some patients having intermediate- or high-risk disease, challenging the notion of GG1 as uniformly low-risk. Removing the cancer label for ...

As the medical school landscape shifts in response to federal pressures and new demands in the healthcare space — such as technological advancements, AI and drug innovations — new physicians may be ...